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ABSTRACT
In oncologic applications of photodynamic therapy (PDT), the discriminating
localization of porphyrin-type compounds in solid tumors is exploited for the selective
ablation of neoplastic tissue with minimal destruction and irritation to normal tissue.
PDT is a locoregional, binary cancer therapy in which a photosensitizer—light-
activated drug—absorbs light of an appropriate wavelength and excites to the singlet state.
This photosensitizer in the excited singlet state can undergo an internal transition to the
excited triplet state, a relatively long-lived and high-energy species that transfers its excess
energy to molecular oxygen. Molecular oxygen subsequently excites from the stable triplet
state to the highly reactive singlet state. With no spin-state restriction, singlet oxygen is
cytotoxic, readily reacting with electron-rich biomolecules such as unsaturated lipids, amino
acids and DNA consequently destroying the tumor cell. Singlet oxygen has a limited range of
diffusion. Therefore, the site of its generation is also the site of initial damage.
Mono-L-aspartyl chlorin e6, a chlorophyll a derivative also known as talaporfin and
subsequently referred to here as NPe6, is a 2nd-generation photosensitizer currently in
advanced-stage clinical trials for PDT. NPe6 is obtained by transesterification of the phytyl
ester group of chlorophyll a with a methyl ester group to form pheophorbide a. Subsequent
isocyclic ring opening forms chlorin e6 trimethyl ester. Alkaline hydrolysis of the methyl
esters and then activation and coupling to a protected aspartic acid followed by deprotections
yields NPe6. The structural elucidation of NPe6 has been performed employing a classical
methodology of an unambiguous synthesis used adjunctively with modern NMR techniques.
The synthesis of NPe6 has been made more efficient via the optimization of the isocyclic ring
opening and coupling reaction. Natural reactivities of chlorophyll a derivatives have been
xexploited to synthesize two regiosomers of NPe6 for biological property investigation. A
novel route to a 173 chlorin e6 derivative has been generated.
Because to date no chlorin photosensitizers have received FDA approval in the United
States, various amino-acid porphyrin conjugates specifically PPIX conjugates have been
synthesized and their preliminary biological evaluation, which demonstrates that subtle
differences in structure can correlate to huge differences in function, is described.
1CHAPTER 1
INTRODUCTION
1.1 Photodynamic Therapy
In oncologic applications of photodynamic therapy (PDT), the discriminating
localization of porphyrin-type compounds in solid tumors is exploited for the selective
ablation of neoplastic tissue with minimal destruction and irritation to normal tissue. PDT is a
locoregional, binary cancer therapy in which a photosensitizer—a light-activated
drug—absorbs light of an appropriate wavelength resulting in its excitation to the singlet
state. This photosensitizer in the excited singlet state can undergo an internal transition to the
excited triplet state, a relatively long-lived and high-energy species that transfers its excess
energy to molecular oxygen. Molecular oxygen subsequently excites from the stable triplet
state to the highly reactive singlet state. With no spin-state restriction, singlet oxygen is
cytotoxic, readily reacting with electron-rich biomolecules such as unsaturated lipids, amino
acids and DNA, consequently destroying the tumor cell.1,2,3 Singlet oxygen has a limited range
of diffusion. Therefore, the site of its generation is also the site of initial damage as seen in
Equation 1.1 and Figure 1.1.
                                                                 
Equation 1.1 Singlet oxygen generation via photosensitization.  P = Porphyrin; ISC =
Intersystem Crossing.
Chemical sensitization with light and acridine was first observed with a paramecium
in 1900 by Raab.4 In 1903, using eosin and sunlight in the treatment of a number of human
2Figure 1.1 Simplified Jablonski diagram showing porphyrin and oxygen singlet and triplet
state. P=Porphyrin;  * = electronically excited state; 0 = ground state; 1 = singlet excited state;
3 = triplet excited state.
3skin conditions, Jesionek and Tappeiner demonstrated the basic principle of PDT.5 See Figure
1.2. Although it can be used as a stand-alone treatment, PDT is also amenable to combination
with other therapies. It can be used adjunctively with chemotherapy, radiotherapy or surgery.6
                      N                                            
O ONaO
Br Br
Br Br
CO2CH3
                        acridine     eosin
Figure 1.2 Early photosensitizers.
Recent studies suggest a synergistic effect is observed when PDT is used with
radiotherapy: Tumor cell destruction occurs to a much greater extent than can be accounted
for simply by the additive effect of PDT and radiotherapy.7
Once limited to the treatment of superficial skin dysplasias, PDT is now utilized in
broader applications. Four photosensitizing drugs have been approved in Canada, the USA
and/or the European Union for the treatment of various malignancies, including cervical
cancer, bladder cancer and cancers of the head and neck. Endoscopic light delivery has made
the irradiation of hollow structures possible allowing PDT of advanced and early lung cancer,
superficial gastric cancer and esophageal cancer. PDT has also benefited from technological
advances in fiber optics, which has made possible precise interstitial light delivery to almost
any internal tumor site in the body including large buried tumors that would normally require
extensive surgery for treatment.8,9,10,11 Now that adequate optical technology is available, the
expanded utility of PDT as a viable, broad-application treatment option for multiple types of
4localized malignancies and pre-malignant diseases largely depends upon improvement of the
biological properties of the photosensitizers employed.
1.2 Porphyrins
The potential of porphyrins as anti-tumor agents in oncology was first fully recognized
in the 1960s with the development of hematoporphyrin derivative (HpD), which showed
selective localization in solid tumors.12 Porphyrins, as illustrated in Figure 1.3, are tetrapyrrole
macrocycles with 22 π conjugated electrons, 18 π of which are in any one delocalized
pathway.13,14 Porphyrins obey Huckel’s rule of aromaticity. As a result of the extended
conjugation, porphyrins are vibrantly colored compounds. The visible absorption spectrum
shows an intense Soret band around 400 nm.
      
NH
N
N
HN
NH
N
HN
N
N
NH
HN
N
Figure 1.3 Porphyrin: 22 π electron tetrapyrrole of which 18 π are in any one delocalized
pathway.
Porphyrins and other closely related tetrapyrrolic pigments occur widely in nature with
significant roles in various biological processes. For example, heme, the iron (II)
protoporphyrin-IX complex, is the prosthetic group in hemoglobins and myoglobins
responsible for oxygen transport in red blood cells and oxygen storage in tissue. Heme, shown
in Figure 1.4, is also found in the enzyme peroxidase that catalyzes the oxidation of substrates
by hydrogen peroxide and the related enzyme catalase.
5                                           
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Figure 1.4 Heme, the iron (II) protoporphyrin-IX complex.
The most significant group of photosynthetic pigments are the chlorophylls, which are
magnesium chelates of the closely related tetrapyrroles. They are present in all organisms that
convert light energy into chemical energy. Chlorophylls are tetrapyrrolic pigments that can be
of the porphyrin, chlorin or bacteriochlorin oxidation state. They are characterized by the
presence of a central magnesium atom and a fifth isocyclic ring that is biosynthetically
derived from the C-13 propionic acid side chain of protoporphyrin.  The biological definition
of chlorophyll varies slightly from this chemical characterization and includes those
tetrapyrrolic pigments active in photosynthetic electron transport, such as pheophytin a the
demetalated form of chlorophyll a. There are more than fifty naturally occurring chlorophylls.
Chlorophyll a is present in all organisms capable of oxygenic photosynthesis. It
functions as the primary photosynthetic pigment acting as the primary donor in the reaction
center of photosystem I and photosystem II and also functions in light-harvesting in the
antenna complexes of oxygenic organisms. Chlorophyll b is present in an approximate ratio of
1:3 with chlorophyll a and functions as a light-harvesting pigment. See Figure 1.5. The C-20
terpenoid alcohol esterifying the C-17 propionic acid side chain is phytol. The term phytyl
refers to the carbon chain itself: (2E)-(7R, 11R), -3, 7, 11, 15-tetramethyl hexadecenyl. The
6phytyl chain is the most common terpene chain of the chlorophylls. There are other chains,
however, such as farnesyl (2 E, 6E)- 3, 7, 11 trimethyl-2, 6, 10 dodecatrienyl. See Figure 1.6.
N
N
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OH3CO2C
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H3C H3CH H
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H3C
OH3CO2C
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O
H3C H3CH H
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CH2 CH3
CH3
CH2
CH3
CH3
Chlorophyll a Chlorophyll b
Figure 1.5 Chlorophyll b varies from chlorophyll a by the presence of a 7-formyl group
instead of a 7 methyl substituent.
                                              
CH3 CH3H H
Phytyl
Farnesyl
Geranylgeranyl
Figure 1.6 The long terpene chain esterified at the C-17 chain is phytyl for chlorophyll a and
chlorophyll b.
7In 1884, Nencki isolated the first pure porphyrin by preparing hematoporphyrin
hydrochloride directly from isolated heme.15 In 1912, Kuster first proposed the structure of
porphyrins as four pyrrole units linked by four methine bridges.16 This structure was later
confirmed in 1926 when Fisher synthesized etioporphyrin-I17 thereby demonstrating that the
aromatic structure initially proposed by Kuster was correct. See Figure 1.7 and Figure 1.8.
Woodward accomplished the first total synthesis of chlorophyll a in 1960.18
In 1975, Dougherty demonstrated HpD19 could selectively destroy tumors upon
irradiation.20 In 1983, a purer form of HpD, now commercially known as Photofrin (porfimer
sodium), was developed. Photofrin received FDA approval in the United States in 1995 and
is now also approved in more than 40 countries. Although Photofrin® has been shown to be
efficacious in the treatment of many cancer types, it has many undesirable properties.
Porphyrins absorb strongly around 500 nm where depth-of-light penetration is weak
due to interference with the absorption of other tissue chromophores, such as hemoglobin in
the blood. Photofrin is not rapidly cleared from normal tissue and exists as a complex
mixture of oligomers. These properties inhibit its generalized use in oncology. Additionally,
side effects such as prolonged skin photosensitivity can make its application inconvenient.
                                                   
NH
N
N
HN
                                                            Tetrapyrrole macrocycle
Figure 1.7 Kuster was the first to propose that porphyrins were tetrapyrrole macrocycles.
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Figure 1.8 Early porphyrins synthesized by Nencki and Fisher.
1.3 NPe6
Development of 2nd-generation photosensitizer candidates has focused on improving
the photophysical and pharmacokinetic properties of potential photosensitizers to increase the
efficacy and expand the utility of PDT, while simultaneously obviating negative side effects
of the currently approved treatments. Mono-L-aspartyl chlorin e6 (1), which is also known as
talaporfin and subsequently referred to here as NPe621, is a 2nd-generation photosensitizer
currently in advanced-stage clinical trials for oncologic PDT applications. As a
chlorin—17,18 dihydroporphyrin—NPe6 has characteristic longer wavelength absorption at
666 nm, which allows for greater depth-of-light penetration and increased photon utilization
than Photofrin. See Figure 1.9, Figure 1.10 and Figure 1.11.
NPe6 is more specifically an aspartic acid conjugate of chlorin e6. Upon irradiation,
NPe6 gives good yields of long-lived triplets (lifetimes, 500 to 800 µs) and therefore gives
high yields of cytotoxic singlet oxygen.22 Additionally, NPe6 shows rapid clearance from
normal tissue. In a direct comparison of NPe6 with Photofrin in PDT of cholangiocarcinoma,
NPe6 was superior to Photofrin at reducing tumor volume, inhibiting tumor regrowth,
9increasing depth of tissue injury (by 67%) and decreasing the troublesome side effect of
cutaneous photosensitization.23   
                                           
Figure 1.9 Chlorin: 20π electron tetrapyrrole of which 18π are in any one localized pathway.
                                                   
                                                                                           1
                                                                                NPe6
Figure 1.10 Mono L-aspartyl chlorin also known as talaporfin and NPe6.
As a chlorophyll-a derivative, NPe6 also possesses additional qualities that rival even
other chlorin photosensitizers. Compared with synthetic chlorins such as temoporfin.24 NPe6
has increased stability since synthetic chlorins can readily oxidize back to porphyrins. See
Figure 1.12. Chlorophyll-a derivatives have increased stability because they possess unusual
structural characteristics not easily accessible with present synthetic methodologies.25,26
Stability is especially significant in binary treatment modalities because degradation products
absorb light outside the laser window consequently making treatment ineffectual.
10
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Figure 1.11 UV-Vis Spectra of Porphyrin and Chlorin.
11
                                 
NH
N
N
HN
OH
HO
OH
HO
meta-tetrahydroxyphenylchlorin
Figure 1.12 Temoporfin is meta-tetrahydroxylphenylchlorin.
Amphiphilicity, another favorable trait, has been shown to improve the effectiveness of
photosensitizers.27 Chlorophyll-a derivatives of the chlorin e6 series possess three carboxylic
side chains, making them ideal substrates for synthesis of novel amphiphilic photosensitizers.
A recent study discovered that small differences in photosensitizer structure, including
regioisomerism, can correlate to huge differences in function, such as subcellular
localization.28 Photosensitizer subcellular localization has recently been demonstrated to be a
factor in the mode of cell damage (i.e. necrosis vs. apoptosis) and therefore helps determine
PDT efficiency.29
The success of NPe6 as a photosensitizer warranted optimization of its synthesis. The
data suggesting that subtle differences in structure can improve biological properties
warranted generation of its regioisomers (2; 3) for comparison. Therefore, in addition to
describing the structural elucidation of NPe6, Chapter 2 of this manuscript also describes an
improved overall synthesis of NPe6 from chlorophyll a and the creation of novel, selective
synthetic routes to the generation of its regioisomers in order to compare the biological
properties. See Scheme 1.1. Of note, one synthetic step — isocyclic ring opening — shared by
 12 
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Scheme 1.1 Synthetic scheme showing generation of three NPe6 isomers from chlorophyll a. Each isomer shares one intermediate step, which has been optimized. The route to the 173 NPe6 is novel and high yielding — 86% overall from chlorophyll a. 
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all three regioisomers has been made highly efficient. These new synthetic methodologies are
now being employed to generate novel chlorin conjugates to study how variation of peripheral
substituents such as other amino acids and other bioactive molecules affect biological properties
such as uptake, cytotoxicity and subcellular localization. We are systematically evaluating the
effects of substituent charge, position and size on these biological properties to better understand
how to improve photosensitizer activity and therefore help increase the efficiency and expand the
utility of PDT.
Because to date NPe6 is still in advanced-stage clinical trials and no chlorin
photosensitizers have received approval in the United States, Chapter 3 is devoted to the
synthesis of various amino-acid porphyrin conjugates—specifically PPIX conjugates—for
biological property investigation, as shown in Scheme 1.2. Preliminary biological evaluation has
demonstrated that once again subtle differences in structure can correlate to huge differences in
function.
NH
N
N
HN
CH2 CH3
H3C CH3
H3C
CO2H CO2H
CH2 NH
N
N
HN
CH2 CH3
H3C CH3
H3C
COR COR
CH2
Scheme 1.2 Synthesis of PPIX derivatives. Chapter 3 describes synthesis where R = Lysine and
R = Glutamate and includes the preliminary biological properties of these compounds.
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CHAPTER 2
CHLOROPHYLL A DERIVATIVES:
STRUCTURAL ELUCIDATION AND EFFICIENT SYNTHESIS
OF MONO-L-ASPARTYL CHLORIN E6 AND ITS CONSTITUTIONAL ISOMERS
2.1 Introduction
Mono-L-aspartyl chlorin e6, also known as talaporfin and subsequently referred to here
as NPe6, is a 2nd-generation photosensitizer in advanced-stage clinical trials for oncologic
applications of photodynamic therapy (PDT). NPe6 is a chlorophyll a derivative. NPe6 is
obtained by transesterification of the phytyl ester group with a methyl ester group to form
methyl pheophorbide a (4). Subsequent isocyclic ring opening forms chlorin e6 trimethyl ester
(5). Alkaline hydrolysis of the methyl esters and then activation and coupling to a protected
aspartic acid followed by deprotection yields NPe6. See Scheme 2.1.
Historically, NPe6 has had a great amount of ambiguity associated with its structure.
Its patent filed in 1987 claimed NPe6 was probably a mixture of regioisomers.1 Because purity
is assured via its isolation by HPLC, academic papers published since 1987 assumed NPe6
was the 173 regioisomer. In 1998, a 2D NMR study published in Heterocycles claimed NPe6
was actually the 152 regioisomer.2 This paper was not unanimously accepted by the porphyrin
community because these studies were performed on the carboxylate salts therefore requiring
dissolution in D2O where chlorin aggregation can seriously complicate NMR analysis.3 Also,
the result was counterintuitive from a mechanistic perspective. The structure remained a
matter of conjecture.
The mechanism allows for ambiguity because no protecting group strategies are
employed in its synthesis and three carboxylic acids exist at the chlorin’s periphery available
for  activation and  coupling. The  reaction is a classic carboxylic acid  activation with DCC as
Chlorin e6 trimethyl ester 
Chlorin e6 
Methyl Pheophorbide a 
Scheme 2.1: Synthetic route of NPe6 from chlorophyll a. 
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the coupling agent, proceeding via a nucleophilic addition subsequent elimination mechanism. 
See Figure 2.1. 
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H
O
NN Transfer 
N DCC 
NH
Proton 
O
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R
+ 
N R C OH
NH dicyclohexylurea 
tetrahedral Rintermediate 
Figure 2.1 Mechanism of carboxylic acid coupling to an amine with DCC coupling reagent. 
According to the nature of the mechanism, it is therefore reasonable to assume that the 
aliphatic 173 carboxylic acid, which is farthest from the aromatic macrocycle and therefore 
less susceptible to the deactivating affects of the ring, would be the most reactive site. 
Additionally, the priopionic side chain’s situation above the plane of the macrocycle makes it 
sterically less inhibited. The 131 carboxylic acid is deactivated because it is attached directly 
to the aromatic macrocycle and the 152 acid presumably suffers from steric restraints. See 
Figure 2.2. Neither was considered serious competition for the 173 carboxylic acid. 
When X-ray crystallography attempts failed at structural elucidation of NPe6, a 
classical methodology of unambiguous synthesis was employed adjunctively with 1D NMR 
and 2D NMR (COSY,TOCSY, HMBC, HSQC) analysis. However, these NMR studies were 
performed on the methyl esters enabling increased organic solubility, which allowed 
acquisition of monomic spectra. Concurrently, another study reported small changes in 
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structure, including regioisomerism, could correlate to huge differences in function, such as 
subcellular localization.4 Subcellular localization has been demonstrated to be a key factor in 
mode of tumor cell damage (i.e. necrosis vs. apoptosis) thereby effecting PDT efficacy.5 
Therefore efficient generation of the regioisomers of NPe6 was warranted for the comparison 
of biological properties and the elucidation of the structure/function relationship. Methyl ester 
protecting groups were consistently utilized to simplify spectra analysis. 
2.2 Unambiguous 173 NPe6 Synthesis 
A new selective route was required for NPe6 synthesis. The demetalated version of 
chlorophyll a is pheophytin a (7). See Figure 2.3. It is the significant compound obtained 
from extraction of Spirulina Maxima. Spirulina Maxima is the ideal chlorophyll a source for 
NPe6 studies because it contains only chlorophyll a and no chlorophyll b, greatly simplifying 
algal extract purification. 
NH
N
N
HN
H3C
CH3H3C
H3CO2C
A
CH3
O
O
H3C H H
B
C
E
D
CH2 CH3
O
H3C
7 
Figure 2.3 Pheophytin a. 
The chemistry of pheophytin and the pheophorbides is dictated by the presence of a β
keto ester on ring E, the isocyclic ring. (This ring is biosynthetically derived from the C-13 
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propionic acid side chain of protoporphyrin.) The ring is susceptible to enolization,6 
decarboxymethylation,7 nucleophilic attack8 and an autoxidation reaction known to 
chlorophyll chemists as “allomerization” See Figure 2.4.9,10 Because of the extremely reactive 
nature of the β keto ester ring, synthetic modifications immediately following extraction 
usually involve either intentional decarboxymethylation or ring opening. 
CONuH3CO2C Ocollidine/
Nu- heat
ROH/O2base
H ROH3CO2C O H3CO2CH3CO2C O O
H2O
O2
HO O OH3CO2C
Figure 2.4 Side reactions of isocyclic ring. 
Wasielewski and Svec demonstrated that the phytyl ester group of pheophytin a (7) 
could be selectively hydrolyzed to form pheophorbide a (8) in high yield (<92%) with 
degassed TFA/H2O (80:20) at 0° for 1 hour without touching the β keto ester of the isocyclic 
ring.11 See Figure 2.5. The feasibility of partial hydrolysis could allow for a unique protecting 
group strategy. If integrity of the isocyclic ring and ß keto ester could be maintained 
throughout coupling conditions, this ring could serve as a natural protecting group during the 
coupling of the free 173 carboxylic acid group to aspartic acid dimethyl ester to form aspartic 
acid dimethyl ester pheophorbide a (9). Subsequent ring opening with methoxide would yield 
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173 NPe6 TME (10) unambiguously. See Figure 2.5. Classical ring opening conditions are to 
treat the pheophorbide with an excess of sodium methoxide in THF.12 To minimize lost 
product because of partial hydrolysis of the ester groups, the solution is treated with 
diazomethane before chromatography.13 Yields are highly variable (from 30% to 60%) under 
these conditions, but starting material is recoverable. 
An unambiguous synthetic route could clarify any confusion associated with the 
structure of NPe6. For structural elucidation purposes, however, rigorous proof of the presence 
of the isocyclic ring and ß keto ester group in steps one and two would have to be provided. 
Degradation of the ß keto ester and/or ring would invalidate the entire structural elucidation 
process. 
The large π system of the chlorin macrocycle produces an induced ring current that 
causes peripheral protons in the plane of the macrocycle to be deshielded. For example, the 
central NH protons are significantly deshielded and appear upfield of TMS. Protons situated 
above and below the plane of the macrocycle are significantly shielded. For pheophytin a (7), 
the meso protons 20, 5 and 10 resonate at δ 9.35, δ 9.50 and δ 8.57. In addition to the 
characteristic chlorin peaks of the meso protons and the central nitrogen protons (among 
others), the significant peaks in this structural elucidation process are the peaks that 
demonstrate the presence of the isocyclic ring and ß keto ester. The diagnostic peaks then for 
pheophorbide a (8), and aspartic acid dme pheophorbide a (9) are the 132 proton δ 6.26 (in 
CDCl3) and the 133 carboxy methyl group δ 3.84 (in CDCl3). Degradation products are easily 
recognized via 1H NMR. The 132 hydroxy degradation product, for example, is missing the 
characteristic 132 proton. 
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Figure 2.5 Unambiguous synthetic route for the generation of 173 NPe6 TME.
Partial hydrolysis of the phytyl group with respect to the 133 carboxy methyl group 
proceeded as predicted from Wasielewski and Svec’s report. Pheophorbide a (8) was obtained 
with a 93% overall yield. The 1H NMR shows the spectrum of the starting material 
pheophytin a (7). The 1H NMR of pheophorbide a (8) shows that the ester and isocyclic ring 
have survived the first step. See Figure 2.6 and Figure 2.7. 
The second step requires the coupling of pheophorbide a (8) with aspartic acid 
dimethyl ester. The coupling reagent DCC was employed with DMAP as a catalyst. The 
reaction was complete within 2 hours and proceeded with a typical coupling yield of 95%. 
Figure 2.8 shows the isocyclic ring has survived the second step as well. It should be noted 
that coupling with modern reagents such as HBTU did not work as the isocyclic ring did not 
survive. 
Step three, the subsequent ring opening step, was easy to follow via UV-Vis. 
Compounds of the chlorin e6 series, i.e. a class of chlorophyll a derivatives without the 
isocyclic ring, have a sharper soret band when compared with the pheophorbides. The 
reaction quickly turned from brown to green upon adding sodium in methanol. The UV-Vis 
(λmax 660, 608, 558, 530, 500, 404) obtained was identical to authentic NPe6 TME. See Figure 
2.9. 
Enthusiasm over the success of the reaction was quickly quenched when the 1H NMR 
of the column purified compound was obtained. The methyl ester region of the spectra 
showed peaks doubled up. It is believed that under these harsh alkaline conditions of extreme 
excess of sodium methoxide, the aspartic acid dimethyl ester substituent racemized from the L 
(S) to the D (R) giving a mixture of  diastereomers  impossible to  separate by gravity  column 
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Figure 2.7 Proton NMR spectrum at 300 MHz in CDCl3 of Pheophorbide a (8) . Red arrows show peaks of isocyclic ring: 132 
proton (δ 6.26) and 133 carboxy methyl group (δ 3.84). 
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Figure 2.8 Proton NMR spectrum at 500 MHz in CDCl3 of Aspartic Acid Dimethyl Ester 
Pheophorbide a (9). Red arrows indicate the presence of the isocyclic ring and β keto ester: 132 
proton (δ 6.26) and 133 carboxy methyl group (δ 3.85). 
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Figure 2.9 UV-Visable absorption sprectra in CDCl3. Top sprectrum is of 173 NPe6
TME. Bottom spectrum is of methylated NPe6 currently in advanced-stage clinical 
trials. 
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chromatography. Amino acids, especially aspartic acid, are sensitive to racemization under 
alkaline conditions.14 
The next strategy was to decrease the amount of methoxide added and perform the 
reaction at 0° C (ring-opening conditions that should maintain the integrity of the aspartic acid 
dimethyl ester’s chiral center). When 1 equivalent of base was added, the reaction proceeded 
smoothly and within 3 hours only one spot was recognizable on silica TLC (2% 
MeOH/DCM). The UV-Vis (λmax 660, 608, 558, 530, 500, 404) was identical to authentic 
NPe6 TME. 
No column was required for purification, only a quick silica plug was run to ensure 
purity and an incredibly unexpected yield of 97% was obtained. The compound was shown to 
be pure via 1H NMR. Additionally mass spectra and C, H, N analysis corroborated the 
compounds identity as 173 NPe6 TME. 
The unexpected yield warranted a closer look at the reaction mechanism. The ring 
opening is a retro Dieckmann. The Dieckmann reaction is an intramolecular (ring closing) 
version of the Claisen condensation to form a five-membered ring with a β keto ester. In the 
Dieckmann condensation—as with most condensations—there exists an equilibrium between 
the starting material and the product. Claisen condensation—and therefore Dieckmann 
condensations as well—are driven forward to completion by an irreversible deprotonation 
step. See Figure 2.10. 
Excess base favors the Dieckmann product. Therefore, if the synthetic objective is the 
retrograde Dieckmann product, less base would be an ally. In fact, only a catalytic amount of 
base is required if the reaction is performed in methanol. After methoxide attacks the carbonyl 
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carbon the carbanion leaving group will rapidly reprotonate from the methanol, regenerating 
methoxide. See Figure 2.11. 
OEtO 
EtOH CO2Et 2 H3C-CO2Et H3C 
series of reversible steps irreversibleEtO deprotonation 
CO2Et H3C 
O 
Figure 2.10 Claisen Condensation.15 
Varying concentrations of catalytic amounts of base were attempted. All proceeded 
with superior yields to standard protocol. But, they were highly variable and not precisely 
repeatable. It is assumed that the inner pyrrole nitrogens could have interrupted the catalytic 
cycle. The reaction will be tried with Mg metalated chlorins to test this theory. It is not 
surprising that entropy would favor the ring opening.16 The extent to which it is favored is 
surprising however. It should be noted that the forward Dieckmann proceeds with high yields 
(87%) when non-nuceleophilic tert-butoxide is used.17 
OMe
NaOMe/MeOH
H O H3CO
H
2CMeO OH3CO2C
CH3-O-H
MeO
CH3-O- H OH3CO2COH3CO2C MeO
Figure 2.11 Mechanism of isocyclic ring opening reaction with methoxide as the nucleophile. 
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The success of the isocyclic ring opening of aspartic acid dme pheophorbide a (9)
encouraged a similar attempt on the more widely utilized chlorin e6 trimethyl ester. Chlorin e6
trimethyl ester (5) is synthesized via the ring opening of methyl pheophorbide a (4). An
optimized yield of 98% of chlorin e6 trimethyl ester was obtained with 1.0 equivalent of
sodium methoxide in methanol. See Figure 2.12.
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Figure 2.12 Improved synthesis of Chlorin e6 trimethyl ester.
The successful synthesis of 173 NPe6 TME (10) allowed comparison of spectra with
authentic NPe6 TME (11). NPe6 was methylated with ethereal diazomethane with a
disappointing yield. Miscibility was a problem. Although diazomethane is an outstanding
reagent for the methylation of porphyrins and chlorins with two and even three peripheral
carboxylic acid, methylation of four peripheral carboxylic acids causes serious solubility
problems. Methylation under phase-transfer catalyzed conditions was tried with TBAB and
methyl iodide. This alkylation technique was not useful. Although the phase-transfer reagent
successfully transferred the chlorin from the aqueous to the organic layer where it could be
methylated, it also catalyzed the methylation of the inner nitrogen atoms as well.
Upon initial inspection of 1H NMR of methylated authentic NPe6 in comparison with 
the related structure, chlorin e6 trimethyl ester (5), it was noticed that the spectrum of 
authentic NPe6 TME was missing the singlet methyl ester peak that resonates at δ 3.73 in 
chlorin e6 trimethyl ester (5). See Figure 2.13 and Figure 2.14. Literature values had 
tentatively assigned this signal to 152 carboxy methyl group reasonably assuming that in 
chlorin e6 trimethyl ester (5) the 152 acetic ester would resonate between the 131 formic ester 
peak at δ 4.24 and the 173 propionic ester peak at δ 3.55. 
Because this 3.50 – 4.24 ppm region plays a critical role in the structural elucidation 
process we decided to more rigorously assign signals in chlorin e6 trimethyl ester (5). This 
spectrum could be an invaluable reference when analyzing spectra of more complex chlorin e6 
derivatives. 2D NMR can be extremely valuable in assigning signals of compounds of known 
structure. Several 2D NMR studies were done—HSQC and HMBC—to definitively 
characterize this region. See Figure 2.15, Figure 2.16 and Figure 2.17. A typical spectrum of 
chlorin e6 trimethyl ester (5) has multiple signals overlapping in the 3.2 and 4.24 ppm region. 
NMRs were obtained on a 500 MHz NMR to obtain better resolution of peaks between 3.2-
4.24 ppm. These studies confirmed the tentative peak assignments. 
The peak that corresponds to the 173 methyl ester peak in the related chlorin e6 
trimethyl ester (5) is present in authentic methylated NPe6. The presence of this methyl ester 
peak suggests an absence of the aspartic acid residue at the 173 position in NPe6 prior to 
methylation, strongly hinting that NPe6 may be the 152 regioisomer. However, the peaks 
resonate too closely together for this argument to be conclusive. For example, it could be 
argued that NPe6 is structurally unique from chlorin e6 and therefore the 152 peak that 
resonates at δ 3.74 in chlorin e6 may actually resonate at δ 3.55 in NPe6. It was therefore 
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necessary to compare the spectra with the unambiguously synthesized 173 NPe6 TME (10). 
TOCSY and COSY were employed to help definitively assign some signals. See Figure 2.18 
and Figure 2.19. 
When comparing the spectra of 173 NPe6 TME and authentic NPe6 TME obtained at 
same concentrations (17 mg/0.5 mL) and on the same instrument (500 MHz spectrometer), it 
is clear that although the spectra are similar, there are key differences. See Table 1. Most 
notably, the absent authentic NPe6 TME ester peak that correlated to the 152 acetic ester peak 
in chlorin e6 trimethyl ester was present in 173 NPe6. The authentic NPe6 ester peak that 
correlated to the 173 propionic ester peak in chlorin e6 trimethyl ester was absent in 173 NPe6. 
There are other minor differences in signals produced by the aspartic acid methyl esters as 
well. This study proves that the NPe6 in advanced staged clinical trials is not the assumed 173 
NPe6. 
2.3 Synthesis of 131 NPe6 
Under acidic conditions the inner nitrogen atoms of chlorin e6 are fully protonated and 
the 131 carboxylic acid becomes severely deactivated. Exploiting the pH sensitivity of the 131 
side chain, the 173 and the 152 carboxylic acids can be selectively methylated with 5% 
H2SO4/MeOH. 
The 131 chain is now available for activation and coupling. After neutralization, 
Chlorin e6 dimethyl ester (12) is readily purified via silica column chromatography. Even 
under the basic conditions required for coupling, the 131 carboxylic acid is still unreactive and 
requires  heating  for  optimal  yields of 131 NPe6 TME. See  Figure 2.20,  Figure 2.21,  Figure 
2.22 and Figure 2.23. 
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Figure 2.13: Proton NMR spectrum at 500 MHz CDCl3 of authentic NPe6 TME (11). 
34
NH
N
N
HN
H3C
CH3H3C
CO2CH3
CO2CH3
CO2CH3
CH2 CH3
CH3
Figure 2.14 Proton NMR spectrum at 500 MHz in CDCl3 of chlorin e6 trimethyl ester (5). 
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Figure 2.15 HSQC spectrum at 500 MHz in CDCl3 of Chlorin e6 trimethyl ester. 
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Figure 2.16 HMBC spectrum at 500 Mhz in CDCl3 of Chlorin e6 trimethyl ester. 
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Figure 2.17 Proton NMR spectrum at 500 MHz in CDCl3 of 173 NPe6 TME. 
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Figure 2.18 COSY spectrum at 500 Mhz in CDCl3 of 173 NPe6 TME. 
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Figure 2.19 TOCSY spectrum at 500 Mhz in CDCl3 of 173 NPe6 TME. 
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Table 1 1HNMR data 500 Mhz in CDCl3 
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Figure 2.20 Proton NMR spectrum at 300 MHz in CDCl3 of chlorin e6 dimethyl ester. 
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Figure 2.21 Proton NMR spectrum at 250 MHz in CDCl3 of 131 NPe6 (13). 
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Figure 2.23 Coupling of aspartic acid dimethyl ester to chlorin e6 dimethyl ester (12). 
2.4 Optimization of 152 Synthesis 
Surprisingly it is the 152 acetic ester group, which is more activated toward coupling. 
At this time the basis of regioselectivity is not know. It should be noted that regardless of 
coupling reagents used (i.e. DCC, EDC, HBTU, OAC), the 152 NPe6 (1) is formed selectively. 
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The uronium/guanidium reagent HBTU, provides the greatest yield. Selectivity is lost when 
reactions of the carboxylic side chain require protic solvents. This finicky selectivity suggests 
that the 173 group is tied up in inter or intramolecular interactions and therefore is not as 
competitive toward coupling in the absence of a protic medium. 
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Figure 2.25 Synthesis of 152 NPe6 (1) via coupling of chlorin e6 (6) to aspartic acid dme. 
2.5 Conclusion 
Employing a classical methodology of unambiguous synthesis in conjuction with 
NMR spectroscopsy the NPe6 in advanced stage clinical trials has been conclusively shown to 
be the 152 NPe6 regioisomer instead of the assumed 173 NPe6 
Natural reactivities of the chlorophyll a derivatives have been exploited to generate 
selective routes for the synthesis of the three regioisomers of NPe6. The route to the 173 NPe6 
TME is exceptionally high yielding (86% overall yield from chlorophyll a) and to our 
knowledge represents a novel route to a 173 chlorin e6 derivative. Synthesis of chlorin e6 
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trimethyl ester, a key step in the synthesis of both the 131 NPe6 and the 152 NPe6, has been
made extremely efficient, with yields of 98%, therefore improving the synthesis of the 152
NPe6 in advanced-stage clinical trials.
2.6 Future Work
For comparison purposes, the three regioisomers of NPe6 TME will be deprotected
and submitted for biological evaluation. The route to the 173 derivative will be extensively
explored. For example, the route for the synthesis of 173 derivatives with amide linkages has
been successful, not surprising because the amide linkage is very stable. The incoming
methoxide nucleophile, which is utilized in the ring opening, is less basic than the nitrogen
leaving group therefore making the amide inert to nucleophilic addition. Could this reaction
be generalized to include ester linkages? For example, could chemoselectivity be
demonstrated for selective nucleophilic addition to the ketone carbonyl of the isocyclic ring
instead of the carbonyl of a 173 ester linkage, thereby increasing the synthetic utility of this
route? These selective routes to the chlorin e6 derivatives can be used as a model for the
synthesis of novel conjugates.
2.7 Experimental to Chapter 2
Isolation of Pheophytin a (7) from Spirulina maxima:
Approximately 700 g of dried Spirulina maxima algae was wetted with acetone and
subsequently slurried with 4 L of liquid nitrogen in a resistant 2 gallon bucket to form a
frozen slush. This slush was allowed to sit for 1 hour after which more liquid nitrogen was
added and was allowed to sit overnight protected from light. The algae was then transferred to
a 4 L reaction vessel and 2 L of acetone was added. The vessel was fitted with a Fisher jumbo
mechanical stirrer with a 46 cm impeller shaft and a 3-neck lid was clamped to the vessel. The
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reaction was heated to reflux under argon with mechanical stirring for 3 hours. The
supernatant was then filtered through Whatman 1 paper on a Buchner funnel and more
acetone was added to the solid. The extraction and filtration process was repeated twice. The
green filtrates were combined and evaporated and then purified by flash column
chromatography on silica gel. Elution first with DCM removed the fast-running yellow
carotenoid band. Then elution with 80:20 DCM/Ethyl Acetate eluted the major blue-grey
pheophytin-a (7) band. 3.9 g  C56H77N4O4 from 700 g algae  (extraction yield without Fisher
Jumbo mechanical stirrer: 500 mg from 700 g algae) UV-Vis (CH2Cl2): λmax (ε/M-1cm-1) 668
(44,600) , 611 (8620 ), 538 (9710), 507 (10,800), 414 (106,000); Mass Spectra (MALDI): m/z
871 (M+H)+; 1H NMR (CDCl3  300 MHz): δ 9.50 (1H, s), 9.35 (1H, s), 8.57 (1H, s), 8.0 (1H,
m), 6.28 (1H, m), 6.26 (1H, s), 6.18 (1H, m), 4.48 (1H, m), 4.21 (1H, m), 3.88 (3H, s), 3.64
(3H, s), 3.60 (1H, q, J = 7.5 Hz ), 3.40 (3H, s), 3.20 (3H, s),  2.63 (1H, m), 2.34 (1H, m)
1.74(3H, d, J = 7.5 Hz), 1.61 (3H, t, J = 7.5 Hz) Phytyl: 5.13 (1H, m), 4.50 (1H, m), 1.90 (2H,
m), 1.56 (3H, m), 1.0-1.3 (2H, m), 0.85 (6H, m) 0.71 (6H, m)
Note: NMR shows minute amounts of the Pheophytin a’, the 132 epimer (diastereomer) of
Pheophytin a (18 S, 17 S 132,S instead of 18 S, 17 S, 132 R).  If the objective is a 173 chlorin
derivative, this epimer is not a nuisance and should not be separated because this will
needlessly diminish overall yield! (The sensitive chiral center is absent in the 173 chlorin
derivative.)
Pheophorbide a (8):
Pheophytin a,(7, 500 mg, 0.57 mmol) was selectively hydrolyzed to the 173 carboxylic acid
without affecting the 131 carbomethoxy group via the Wasielewski and Svec procedure which
requires stirring pheophytin a (7) in 75 mL of degassed TFA/H2O  80:20  at 0° for 1 h11. The
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reaction mixture was poured into 500 mL of H2O and extracted with CHCl3. The extract was
washed three times with H2O and twice with 10% NaHCO3, then dried over anhydrous
Na2SO4. Evaporation of solvent provided a brown residue that was purified via silica gel
column chromatography with 40% Ethyl acetate in DCM. Alternatively the residue can be
purified as reported by Wasielewski and Svec via a column of powdered confectioner’s sugar
(3-8 cm x 30 cm columns, elution with 10% acetone in CCl4) 311 mg; 93% of C35H36N4O5
was obtained. UV-Vis (CH2Cl2): λmax (ε/M-1cm-1) 667 (55,200), 609 (7900), 535 (9470), 505
(12, 100), 413 (119, 200) Mass Spectra  (MALDI): m/z 593 (M+H)+; 1H NMR  (CDCl3, 300
MHz ): δ 9.51 (1H, s), 9.37 (1H, s), 8.59 (1H, s), 7.97 (1H, m), 6.28 (1H, m), 6.26 (1H, s),
6.18 (1H, m), 4.43 (1H, m), 4.16 (1H, m), 3.84 (3H, s), 3.67 (3H, s), 3.63 (1H, q, J = 7.5 Hz),
3.40 (3H, s), 3.21 (3H, s), 2.54 (1H, m), 2.21 (1H, m), 1.74 (3H, d, J = 7.5 Hz), 1.62 (3H, t, J
= 7.5 Hz)
Aspartic Acid Dimethyl Ester Pheophorbide a (9):
Pheophorbide a, (8, 100 mg; 0.169 mmol) was dissolved in 75 ml Dry CH2Cl2 and 1 mL TEA.
DCC (40 mg, 0.194 mmol) and DMAP (25 mg, 0.2 mmol) and L-aspartic acid dimethyl ester
(45 mg, 0.228 mmol) were added and the reaction was stirred for 2 hours. Note: this reaction
is favored by dilute conditions. Concentrated conditions favors formation of the anhydride
(bispheophorbide) and not the aspartic acid dimethyl ester pheophorbide a product. The
reaction mixture was washed with water and brine, dried over sodium sulfate and then
purified on a silica column (30% Ethyl Acetate in DCM) DCC is persistent. After the major
brown band was eluted from the column, the solvent was evaporated and the solid was
dissolved in 100% ethyl acetate and filtered. This step was repeated three times. (DCC
precipitates in ethyl acetate.) Evaporation of ethyl acetate gave 118 mg, 95% of aspartic acid
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dme pheophorbide a (9), C41H45N5O8. UV-Vis (CH2Cl2):  λmax  (ε/M-1cm-1) 667 (55,300), 611
(7890), 535 (9490), 505 (12, 100), 413 (119, 400); Mass Spectra (MALDI): m/z  737 (M+H)+;
1H NMR  (CDCl3, 500 MHz ): δ 9.50 (1H, s), 9.38 (1H, s), 8.57 (1H, s), 8.0 (1H, m), 6.29
(1H, m), 6.26 (1H, s), 6.18 (1H, m), 4.71 (1H, m), 4.47 (1H, m), 3.85 (3H, s), 3.68 (3H, s),
3.65 (3H, s), 3.63 (1H q, J = 7.5 Hz), 3.47 (3H, s), 3.39 (3H, s), 3.21 (3H, s), 2.88 (1H, m)
2.65 (1H, m),  2.54 (1H, m), 2.21 (1H, m), 1.74 (3H, d, J = 7.5 Hz), 1.62 (3H, t, J =7.5 Hz);
13C NMR (CDCl3): δ 189.6, 172.4, 171.7, 171.4, 171.0, 169.6, 161.2, 156.6, 152.2, 149.7,
145.2, 142.1, 137.9, 136.6, 136.7, 136.3, 132.0, 129.1, 129.1, 128.1 122.8, 105.3, 104.4, 97.6,
94.0, 64.7, 52.8, 52.7, 51.9, 51.1, 50.1, 48.2, 35.8, 32.6, 29.9, 23.1, 19.5, 17.4, 12.1, 12.1 11.3
173 Monoaspartyl Chlorin e6 Tetramethyl Ester (10):
Aspartic Acid Dimethyl Ester Pheophorbide a (9), (100 mg, 0.135 mmol) was dissolved in
dry methanol and stirred under argon for 10 minutes. Sodium methoxide (0.27 mL of a 0.5 M
solution) was added and the reaction was allowed to stir at 0°C for one hour. The reaction was
followed by UV-Vis. The solution turns from brown to green as the isocyclic ring opens. The
reaction mixture was then poured into water. The mixture was extracted with CH2Cl2 and the
organic layer was washed with water, dried over sodium sulfate and then evaporated. The
residue was dissolved in 2% Methanol/DCM and purified on a silica plug with same mobile
phase. Solvent was evaporated and 100 mg, 97% of C42H49N5O9 (10) was obtained. UV-Vis
(CH2Cl2):  λmax  (ε/M-1cm-1) 660, 608, 558, 530, 500, 404; Mass Spectra (MALDI): m/z 768 (M
+ H)+ HRMS requires 767.87 found 767.947; 1H NMR (CDCl3, 500 MHz ): δ 9.61 (1H, s),
9.48 (1H, s), 8.67 (1H, s), 7.98 (1H, m), 6.30 (1H, dd, J = 17.8, 1.5), 6.0 (1H, br s), 6.06 (1H,
dd, J = 11.5, 1.5), 5.22 (2H, br ), 4.74 (1H, ddd J = 8.1, 4.6, 4.6), 4.37 (q, J= 7.3), 4.19 (3H,
s), 3.71 (3H, s), 3.70 (1H, q, J = 7.6) ), 3.59 (3H, s), 3.49 (3H, s), 3.45 (3H, s), 3.40 (3H, s),
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3.22 (3H, s),  2.81 (2H, dd,  J = 17.2, 4.6), 2.21 (m), 1.66 (3H, d, J = 7.3), 1.61 (3H, t, J = 7.6)
-1.34 (s), -1.48 (s); 13C NMR (CDCl3): δ 174, 172.3, 171.5, 171.1,169.8, 169.3, 166.7, 154.9,
148.6, 145.0, 139.5, 136.4, 135.9, 135.4, 135.3, 134.7, 130.4, 129.2, 129.1 123.5, 121.6,
102.3, 102.0, 98.4, 93.4, 52.9  52.8, 52.7, 51.9,  49.4, 48.1, 38.4, 35.8, 32.3, 30.1, 22.9, 19.5,
17.7, 12.0, 11.2; Elemental Analysis: Anal Calc for C42H49,N5O9 C, 65.69, H, 6.43, N, 9.12.
Found: C, 65.30, H, 6.47, N, 8.95
173 Monoaspartyl Chlorin e6 (2):
Monoaspartyl Chlorin e6 tetramethyl ester (10) was dissolved in dry CH2Cl2. LiI was added
and allowed to stir for 1 hour. UV-Vis (acetone): λmax  (ε/M-1cm-1) 664 (45,400), 610 (4,600),
560 (2,000), 530 (4,900), 502 (12,300), 402 (135,200); Mass Spectra m/z 712 (M + H)+; 1H
NMR  (D2O 300 MHz ): δ 9.30 (1H, s), 9.11 (1H, s), 8.0 (1H, m), 7.03 (1H, s), 6.84 (1H, dd, J
= 17.8, 11.7 Hz), 5.49-5.51 (2H, m), 4.85 (1H, m), 3.64 (3H, s), 3.18 (3H, s), 2.30-2.68 (2H,
m), 3.00 (2H, m), 2.76-2.68 (2H, m), 1.81 (3H, d J = 7.1 Hz). 1.23 (3H, t, J = 7.6 Hz)
Methyl Pheophorbide a (4):
Method 1: Algal extract was treated with 5% sulfuric acid in methanol (degassed by bubbling
with argon) for 12.5 h at room temperature under argon and protected from light. It was
diluted with CH2Cl2, washed with water and then 10% saturated aqueous sodium bicarbonate.
The aqueous layer was dried over sodium sulfate, filtered and then evaporated.
Recrystallization of the residue from CH2Cl2 and methanol gave the product.
Method 2: Pheophorbide a, (100 mg; 0.169 mmol), was treated with ethereal diazomethane.
Argon was flushed through the flask and the solution was evaporated and recrystallized from
CH2Cl2 and Methanol to quantitatively give 102 mg the product, C36H38N4O5 (4) UV-Vis
(CH2Cl2): λmax (ε/M-1cm-1) 668 (40,700), 610 (8100), 560 (3200), 538 (9400), 506 (10,400),
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412 (93,400); 1H NMR  (CDCl3, 300 MHz ): δ 9.50 (1H, s), 9.36 (1H, s), 8.57 (1H, s) 8.0 (1H,
m), 6.29 (1H, m), 6.26 (1H, s), 6.16 (1H, m), 4.46 (1H, m), 4.20 (1H, m), 3.88 (3H, s), 3.70
(2H, q, J = 7.6), 3.68 (3H, s), 3.57 (3H, s), 3.41 (3H, s), 3.25 (3H, s), 2.63 (1H, m), 2.32 (1H,
m), 2.52 (1H, m), 2.2 (1H, m), 1.81 (3H, d, J = 7.3) 1.69 (3H, t, J = 7.6),  0.53 and -1.67 (2H,
br, s)
Chlorin e6 Trimethyl Ester (5):
Methyl Pheophorbide a, (4, 102 mg, 0.168 mmol),  was dissolved in dry methanol and stirred
under argon for 10 minutes. 0.35 mL of a 0.5 M sodium methoxide solution was added to the
solution and was allowed to stir for 2 hours at 0° C. The solution was diluted with H2O and
extracted with CH2Cl2. The organic layer was dried with sodium sulfate, filtered and then
evaporated. The solid obtained was dissolved in CH2Cl2 and chromatographed on a plug of
alumina (grade III) with the same mobile phase. Chlorin e6 trimethyl ester eluted with CH2Cl2.
After evaporation, 105 mg, 98% of C37H42N4O6 (5) was obtained. UV-Vis (CH2Cl2): λmax (ε/M-
1cm-1) 666 (43,700), 608 (4530), 558 (1740), 530 (4700), 500 (11,240), 404 (123,400); Mass
Spectra  (MALDI): m/z 639 (M+H)+; 1H NMR (CDCl3, 500 MHz ): δ 9.63 (1H, s), 9.45 (1H,
s), 8.71 (1H, s), 7.96 (1H, m), 6.27 (1H, dd, J = 17.8, 1.5 Hz), 6.04 (1H, dd, J = 11.5, 1.5 Hz),
5.37 (2H, d, J = 18.8 Hz), 5.21 (1H, br d, J = 18.8 Hz), 4.43 (2H, m), 4.24 (3H, s) 3.76 (3H,
s), 3.74 (2H, q, J = 7.3),  3.56 (3H, s), 3.55 (3H, s), 3.39 (3H, s), 3.19 (3H, s), 2.56 (2H, m),
2.18 (2H, m), 1.75 (1H, m), 1.67 (3H, d, J = 7.3 Hz),  1.64 (3H, t, J = 7.7 Hz), -1.33 (1H, s), -
1.47 (1H, s); 13C NMR (CDCl3, 500 MHz ): δ 174, 173.1, 169.6, 169.6, 167, 154.8, 148.9,
144.8, 139.5, 136.4, 134.7, 135.9, 135.3, 135.4, 130.5, 129.3, 129.3, 123.3, 121.2, 102.2,
102.1, 99, 93.6, 53.0, 52.9, 52.1, 51.6, 49.4, 38.7, 29.1, 27.6, 22.9, 19.6, 17.7, 12.1, 12.0, 11.3
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Chlorin e6 (6):
Chlorin e6 trimethyl ester (5, 100 mg, 0.157 mmol) was dissolved in 25% aqueous DMF.
KOH was added and the reaction stirred at 60° C for 12 hours. The reaction mixture was
diluted with water and adjusted to pH 3 with aqueous citric acid and washed with CH2Cl2. The
solution was evaporated and redissolved in acetone and evaporated several times. The solid
was washed with water and then dried under vacuum. The residue was dissolved in methanol
and purified on a Sephadex LH20 column to yield 40 mg, 43% of C34H36N4O6. This reaction is
currently being optimized with LiI. UV-Vis (CH3OH): λmax (ε/M-1cm-1) 666 (45,271), 610
(8706), 558 (7835), 530 (9721), 502 (15,525), 402 (145,100); Mass Spectra MALDI: m/z 597
(M + H)+; 1H NMR (CD3)2SO δ: 9.65 (1H, s), 9.57 (s, 1H), 8.80 (s, 1H), 8.0 (1H, m), 6.40
(2H, dd, J = 17.1, 11.5 Hz),  5.40 (2H, m), 4.45 (2H, m), 3.78 (2H, q, J = 7.3), 3.61 (3H, s),
3.25 (3H, s), 2.70-2.20 (4H, m), 1.78 (3H, t, J = 7.1 Hz), 1.72 (3H, d, J = 6.8), -1.50 (1H, s), -
1.72 (1H, s)
Chlorin e6  dimethyl ester (12):
Chlorin e6, (6, 75 mg, 0.126 mmol) was dissolved in 5% sulfuric acid and methanol and
allowed to stir protected from light, under argon overnight. The reaction was poured into cold
saturated aqueous NaHCO3 and extracted twice with CH2Cl2. The extract was washed twice
with brine, dried over Na2SO4 and filtered. The solvent was evaporated and redissolved in
CH2Cl2. It was then purified on a silica column. Development with 6% methanol and CH2Cl2
eluted the major green fraction which was collected. Solvent was removed to afford 75 mg,
95% of C36H40N4O6 (12). UV-Vis (CHCl3): λmax (ε/M-1cm-1) 666 (49,700), 610 (5,900), 562
(2,700), 523 (5,900), 502 (13,200) 402 (143,400); Mass Spectra (MALDI): m/z 625 (M + H)+;
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1H NMR(CDCl3, 300 MHz ): δ 9.65 (1H, s), 9.52 (1H, s), 8.72 (1H, s), 8.06 (1H, m), 6.32
(1H, dd, J = 17.8, 1.2 Hz), 6.13 (1H, dd, J = 11.5, 1.2 Hz), 5.50 (1H J= 18.6 Hz), 5.23 (1H, d,
J = 18.6 Hz), 4.45 (1H, m), 3.82 (3H, s), 3.76 (2H, q,  J = 7.6 Hz), 3.60 (3H, s), 3.59 (3H, s),
3.46 (3H, s), 3.28 (3H, s), 1.69 and  2.12 (2H, m), 2.19 and 2.56 (2H, m), 1.81 (3H, d, J = 7.1
Hz), 1.64 (3H, t, J = 7.6 Hz); 13C NMR (CDCl3, 300 MHz): δ 174, 170.5, 168, 153.8, 147.7,
144.9, 140, 138, 137, 135.6, 135.1, 129, 122.4, 122.1, 102.5, 51.7, 52.3,  29.3, 38.9, 23, 18,
12.8, 11
131 Monoaspartyl Chlorin e6 Tetramethyl Ester (13):
Chlorin e6, dimethyl ester (12, 75 mg, 0.120 mmol) was dissolved in dry CH2Cl2 with 1 ml
TEA. HBTU (136 mg, 0.36 mmol) was added and allowed to stir until completely dissolved.
Then Aspartic Acid dimethyl ester was added. The reaction was allowed to stir overnight. The
mixture was diluted with CH2Cl2 and then washed with 5% aqueous citric acid, followed by a
wash with brine and water. It was dried over sodium sulfate and then evaporated. The residue
was dissolved in 2% Methanol/DCM and purified via silica column chromatography with the
same mobile phase to yield  C42H49N5O9 UV-Vis (CH2Cl2): λmax (ε/M-1cm-1) 660, 608, 558,
530, 500, 404; Mass Spectra (MALDI): m/z 768 (M + H)+; 1H NMR (CDCl3, 300 MHz ) δ
9.70 (1H, s), 9.62 (1H, s), 8.78 (1H, s), 8.08 (1H, m), 6.35 (1H, dd,, J = 17.8, 1.5 Hz), 6.12
(1H, dd, J = 11.5, 1.5 Hz),  5.56 (1H, d, J = 18.8 Hz),  5.48 (1H,  J = 8.1, 4.6, 4.6 Hz) 5.39 d,
J = 8.1), 4.45 (2H, m), 3.96 (3H, s), 3.77 (3H, s), 3.80 (2H, q, J = 7.7 Hz), 3.66 (3H, s), 3.62
(3H, s), 3.60 (3H, s), 3.60 (3H, s), 3.50 (3H, s), 3.33 (3H, s), 2.55-2.16 (4H m), 1.74 (m), 1.70
(3H, d J = 7.2 Hz), 1.68 (3H, t, J = 7.7 Hz), -1.47 (1H, s), -1.53 (1H, s)
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152 Monoaspartyl Chlorin e6 Tetramethyl Ester (11) :
Chlorin e6 (6, 75 mg, 0.126 mmol) was dissolved in dry CH2Cl2 with 1 ml TEA. HBTU  (57
mg, 0.15 mmol) was added and allowed to stir until completely dissolved. Then aspartic acid
dimethyl ester hydrochloride was added. The reaction was allowed to stir for 2 hours. The
mixture was diluted with CH2Cl2 and then washed with 5% aqueous citric acid, followed by a
wash with brine and water. It was dried over sodium sulfate and then evaporated. Then it was
dissolved in CH2Cl2 and treated with ethereal diazomethane. The residue was dissolved in 2%
Methanol/DCM and purified via silica column chromatography with the same mobile phase to
afford 60 mg, 61% of C42H49N5O9. UV-Vis (CH2Cl2): λmax (ε/M-1cm-1) 660, 608, 558, 530, 500,
404; Mass Spectra (MALDI) m/z 768 (M + H)+; 1H NMR (CDCl3, 300 MHz ) δ 9.62 (1H, s),
9.50 (1H, s), 8.69 (1H, s), 7.95 (1H, m), 6.30 (1H, dd, J = 17.8, 1.5 Hz), 6.07 (1H, dd, J =
11.5, 1.5 Hz), 5.22 (2H, br), 4.76 (1H, ddd, J = 8.1, 4.9, 4.4 Hz), 4.40 (1H, m), 4.19 (3H, s),
3.71 (2H, q, J = 7.3 Hz), 3.50 (3H, s), 3.49 (3H, s), 3.40 (3H, s),  3.31 (3H, s), 3.22 (3H, s),
3.01 (3H, s), 2.78 (2H, dd, J = 16.8, 4.4 Hz) 2.56 and 2.21 (2H, m), 1.66 (2H, m), 1.65 (3H, d,
J = 7.3 Hz), 1.61 (3H, t, J = 7.7 Hz), -1.34 (1H, s), -1.48 (1H, s)
152 Monoaspartyl Chlorin e6 (1):
152 Monoaspartyl Chlorin e6 Tetramethyl Ester was dissolved in dry DCM and LiI was added
and allowed to stir. UV-Vis (acetone)  λmax  (ε/M-1cm-1) 664 (45,400), 610 (4,600), 560 (2,000),
530 (4,900), 502 (12,300), 402 (135,200); Mass Spectra m/z 712 (M + H)+; 1H NMR
(CD3)2SO: δ 9.56 (1H, s), 9.43 (1H, s), 8.68 (1H, s), 7.95-7.85 (1H, m), 7.10-7.04 (1H br s),
6.40 (1H, dd, J = 17.8, 11.6), 6.10 (1H, dd, J = 11.6, 1.4 Hz),  4.715-4.674 (1H, m), 4.70 (1H,
m), 4.43 (1H, m), 3.59 (2H, m), 3.50 (3H, s), 3.30 (3H, s), 3.13 (3H, s), 2.78-2.68 (2H, m),
2.61-2.29 (2H, m), 1.70 (3H, t, J = 7.3 Hz), 1.63 (3H, d, J = 7.3 Hz) -1.903 (2H, s)
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Generation of Diazomethane:
Assemble special diazomethane distillation equipment. Fill condenser with dry ice, then add
acetone slowly until cold finger is 1/3 full. Add ethanol (95%, 10 ml) to a solution of KOH
(5g) in H2O (8 mL) in reaction vessel. Attach a 100 mL receiving flask with clear seal joint to
condenser and cool receiver in ice bath. Provide an ether trap at the side arm. Cool trap with
NaCl ice bath (33 g NaCl, 100g ice) Place separatory funnel over reaction vessel and charge
funnel with solution of Diazald in ether. Warm reaction vessel to 65° C with H2O bath add
Diazald over a 20 minute periord. Rate of distillation should equal rate of addition. Replenish
cold finger with dry ice as necessary. When all Diazald has been consumed, slowly add 10
mL of ether until distillate is colorless. Neutralize any excess CH2N2 with acetic acid or on
small scale, bubble argon through solution.
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CHAPTER 3
NATURAL PORPHYRIN DERIVATIVES:
AMINO ACID CONJUGATES OF PROTOPORPHYIN IX
3.1 Introduction 
This chapter explores the synthesis and preliminary biological property investigation1of 
novel protoporphyrin IX (PPIX) amino acid conjugates as part of our ongoing research in the 
development of more efficacious naturally-derived photosensitizers for PDT. PPIX (14) is an 
ideal candidate for the synthesis of various novel photosensitizers because it has two peripheral 
carboxylic acids available for coupling. See Figure 3.1. Note in this investigation all amino acids 
conjugated to PPIX are proteogenic (i.e. L (S) isomer). 
HN
NNH
N
H3C
CH3
CO2H CO2H
CH2
CH3
CH2
H3C
14 
Protoporphyrin IX 
Figure 3.1 Protoporphyrin IX has two peripheral carboxylic acid groups available for coupling. 
3.2 PPIX Dilysine and PPIX Diglutamate Synthesis 
PPIX was coupled with tert-butyl ester protected glutamic acid. The PPIX diglutamate 
tetratertbutyl ester (15) was isolated and characterized. Subsequent deprotection with TFA 
yielded PPIX diglutamate (16). See Figure 3.2. In a separate coupling experiment, PPIX was 
conjugated to NBoc, t-butyl ester protected lysine. The intermediate (17) was isolated and 
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characterized. See Figure 3.3 and Figure 3.4. Subsequent deprotection with TFA yielded
PPIX dilysine (18).
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Figure 3.2 Coupling of PPIX to L-glutamic acid.
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Figure 3.3 Coupling of PPIX (14) to lysine. 
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     Figure 3.4 Representative proton NMR spectrum of a PPIX diamino acid conjugate. Spectrum at 500 MHZ
     in CDCl3 of PPIX dilysine [(Nboc)(OtBu)]2
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BocHNBocHN
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N
H3C
CH2
H3C
CH3
CH2 CH3
O
3.3 Preliminary Biological Property Investigation 
The therapeutic effect of a photosensitizer is influenced by the amount of the drug 
incorporated by the cell, localization of the drug within the cell and the amount of cell kill. In an 
effort to expand the utility of PDT by improving the efficacy of the photosensitizers employed, 
we are screening our novel compounds by investigating key biological properties such as uptake, 
cytotoxicity and intracellular localization. 
Variation of peripheral side chain from diglutamate to dilysine has a profound effect on 
both uptake and cytotoxicty. Figure 3.5 shows the time-dependent uptake by human epithelial 
cells (HEp2) of PPIX diglutamate (16) and PPIX dilysine (18) for a period of 24 hours. PPIX 
diglutamate’s (16) accumulation leveled at less than 0.01 µM/1000 cells after 2 hours, while 
PPIX dilysine (18) continued to accumulate even after 8 hours, ultimately reaching an 
intracellular concentration of 0.04 µM/1000 cells. 
Likewise, PPIX dilysine (18) was more cytotoxic than PPIX diglutamate (16), probably 
as a result of its greater accumulation within the cell. Whereas administration of PPIX 
diglutamate resulted in minimal cell death. The IC50 (inhibitory concentration 50) dose for PPIX 
dilysine was 110 µM. See Figure 3.6. Unlike uptake and cytotoxicity, however, both compounds 
exhibited the same intracellular localization behavior. Both PPIX dilysine (18) and PPIX 
diglutamate (16) localized in the lysosomes. See Figure 3.7. 
3.4 Conclusion 
Two PPIX conjugates have been synthesized. PPIX dilysine (18) and PPIX diglutamate 
(16) demonstrate how variation of peripheral substituent can effect biological properties such as 
upake and cytotoxicity. PPIX dilysine (18) not only accumulated to a greater extent within HEp2 
cells, it also resulted in superior cytotoxicity. 
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Figure 3.5: This figure shows time-dependent uptake for PPIX dilysine and PPIX diglutamate in 
HEp2 cells. PPIX dilysine shows greater uptake than PPIX diglutamate. 
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Figure 3.6: Cytotoxicity study of PPIX dilysine (18) and PPIX diglutamate (16). 
PPIX diglutamate (16) is nontoxic to HEp-2 cells regardless of concentration. PPIX 
dilysine (18) IC50 is 110 µM. 
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ER Tracker 
(ER) 
BODIPY 
(Golgi) 
Lysosensor
(Lysosomes) 
Mitotracker 
(Mitochondria) 
Hoechst 
(Nucleus) 
Figure 3.7: Intracellular localization of PPIX diglutamate (16) in HEp2 cells after 24 hour 
incubation. a) Phase Contrast h) Colocalization with lysosome observed. 
64
65
3.5 Experimental
Synthesis of PPIX diglutamate tetratertbutyl ester (15):
PPIX (1, 100 mg, 0.178 mmol, 1 eq) was dissolved in approximately 75 ml of dry DCM. TEA
(1 ml) was added . The solution is heated gently to 35°C to fully dissolve the PPIX. HBTU
(202.5 mg, 0.531 mmol, 3 eq) was added and the solution was stirred vigorously for 5
minutes. Diterbutyl glutamate hydrochloride salt (158 mg, 0.51 mmol, 3 eq.) was added and
the solution was stirred at 35 °C for about 20 minutes. Then it was stirred at room temperature
for 6 hours. The mixture was washed with water three times. It was then dried over sodium
sulfate and filtered. DCM was evaporated. The residue was redissolved in DCM and purified
over Grade III alumina in DCM. Pure DCM was rinsed through the column to remove any
residual amino acid (not coupled to the PPIX). Then with 1% MeOH and DCM the product
PPIX diglutamate was eluted. (alternatively you can use silica 20% acetone and DCM but this
is not recommended if you have a free amine group anywhere in your compound.) Yield 168
mg (90%) UV-VIs (CH2Cl2) λmax (ε/M-1 cm-1)  406, 505, 540, 578; Mass Spectra (MALDI)
m/z  1046 (M+H)+; 1H NMR: (CDCl3 300 MHz) δ 10.20 (1H, s), 10.18 (1H, s), 10.15 (1H, s),
10.06 (1H, s) 8.23 (2H, m), 6.41 (2H dd, J = 12 Hz, J = 2 Hz), 6.17 (2H, dd, J = 19, J = 2),
4.31 (6H, m), 3.72 (3H, s), 3.71 (3H, s), 3.64 (3H, s), 3.63 (3H, s), 3.19 (4H, m), 1.57-1.86
(8H, m), 1.03 (18H, s), 1.04 (18H, s), -3.5 (2H, br, s)
PPIX diglutamate (16):
PPIX diglutamate tetratertbutylester (15, 100 mg, 0.096 mmol) was deprotected via stirring in
neat TFA for 10 minutes. TFA was evaporated. The residue was precipitated with ethyl ether.
The precipitate was washed 5 times with ether and then let dry under vacuum. The precipitate
was redissolved in methanol and purified on a Sephadex column (100% methanol). The
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compound was eluted and the methanol was evaporated and dried under high vacuum. Yield
is quantitative 78 mg 100%.UV-Vis (MeOH) λmax (ε/M-1 cm-1) 415 (174,658), 545 (14,384),
583 (15,753); Mass Spectra (MALDI) m/z  820 (M + H)+ ;1H NMR (CD3)2SO) δ 12.3 (4H, br
s), 10.29 (1H, s), 10.22 (1H, s), 10.20 (1H, s), 10.29 (1H, s), 8.22 (2H, m),  6.45 (2H dd, J =
12 Hz, J = 2 Hz), 6.20 (2H, dd, J = 19, J = 2) 4.31 (6H, m), 3.72 (3H, s), 3.70 (3H, s), 3.60
(3H, s), 3.58 (3H, s), 3.14 (4H, m), 2.08 (4H, m), 2.06 (2H, m), 1.80 (2H m), -4.02 (2H, s)
Synthesis of PPIX dilysine [(NBoc)(OtBu)]2  (17):
See procedure for synthesis of 15 Expect yields  of 17 to be slightly lower than yields of 16 .
UV-VIs (CH2Cl2) λmax (ε/M-1 cm-1)  406 , 505, 540, 578 Mass Spectra (MALDI) m/z  1132
(M+H)+; 1H NMR: (CDCl3 300 MHz) δ 10.24 (1H, s), 10.20 (1H, s), 10.16 (1H, s), 10.07 (1H,
s) 8.16 (2H, m), 7.02 (2H, br s), 6.42 (2H, dd J = 11.5 Hz, J = 1.5 Hz), 6.28 (2H, dd, J = 17.5
Hz, J = 1.5 Hz), 4.2-4.4 (6H, m), 3.74 (3H, s), 3.72 (3H, s), 3.67 (3H, s), 3.65 (3H, s), 3.2-3.4
(4H, m), 3.59 (4H, m), 3.16 (4H, m) 0-1.9 (8H, m) 1.22 (36 H, s)
PPIX dilysine (18)
See procedure for synthesis of 16 UV-VIs (CH2Cl2) λmax (ε/M-1 cm-1) 415 (138,776), 545
(9524), 582 (10,204)  Mass Spectra (MALDI) m/z  1132 (M+H)+ 1H NMR: (CDCl3 300 MHz)
δ 10.43 (1H, s), 10.35 (1H, s), 10.30 (1H, s), 10.28 (1H, s), 8.26 (2H, m), 7.4 (6H, br s), 6.45
(2H dd, J = 12 Hz, J = 2 Hz), 6.20 (2H, dd, J = 19, J = 2), 4.31 (6H, m),  3.81 (3H, s), 3.79
(3H, s), 3.68 (3H, s), 3.65 (3H, s), 3.16 (4H, m), 1.0-1.5 (18H, m)
3.6 References
1 Biological property investigation by Timothy Jensen.
APPENDIX A: PORPHYRIN NOMENCLATURE
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Figure 1 Oxidation states of tetrapyrrole ring. A is a porphyrin. B is a chlorin 
(dihydroporphyrin). C is a bacteriochlorin (tetrahydrochlorin). 
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APPENDIX B: CHARACTERIZATION OF COMPOUNDS
Instrumental Analysis
UV-Vis:  Electronic absorption spectra were measured using a Perkin-Elmer Lambda
35 UV-Vis spectrophotometer.
MS: MALDI: Matrix Assisted Laser Desorption/Ionization (LSU Mass Spectrometry
facility).
NMR:  1H NMR spectra were recorded on a Bruker AC 250 MHz, Bruker ARX-300
MHz and Bruker AMX 500 MHz. 13C spectra were recorded on the Bruker AMX 500
MHz.
Deuterated solvents: CDCl3: 7.26 ppm, (CD3)2SO: 2.54  ppm, CD3OD: 3.34 ppm
Chemical shifts (δ) are given in parts per million relative to tetramethylsilane (TMS, 0
ppm); multiplicities are indicated as s (singlet), d  (doublet), dd (doublet of doublets), t
(triplet), q (quartet) and m (multiplet).
Elemental Analysis: Midwest Microlab Indianapolis, Indiana.
Chromatographic Methods
Column Chromatography: Three types of packing material were employed: E.
Merck neutral alumina (70-230 mesh), Merck silica gel 60 and Sephadex LH20.
Alumina was deactivated with with either 6% water (activity III) or 15% water
(activity V) before use. Sephadex LH20 was purchased from Amersham Biosciences
(Sweden) and was allowed to absorb methanol overnight prior to each use.
Analytical TLC: TLC was performed on Scientific Adsorbent Company Inc., silica or
alumina gel plate.
Purification of Solvents and Reagents
Dichloromethane: distilled from calcium hydride
Methanol: distilled over magnesium turnings
Tetrahydrofuran (THF): distilled from Na/benzophenone
Toluene: distilled from Na/benzophenone
Triethylamine: stored over 4A molecular sieves
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